These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2917483)

  • 21. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracavernous injection therapy for male erectile dysfunction.
    Fallon B
    Urol Clin North Am; 1995 Nov; 22(4):833-45. PubMed ID: 7483132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Papaverine-induced priapism. Experiences with a new urologic emergency].
    Schneider AW; Busch R; Gonnermann D; Klosterhalfen H
    Dtsch Med Wochenschr; 1989 Feb; 114(6):214-7. PubMed ID: 2917481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic injection therapy.
    Zorgniotti AW
    Semin Urol; 1986 Nov; 4(4):233-5. PubMed ID: 3797892
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intracavernous injections of vasoactive drugs. Contribution to the study of their value in erectile impotence].
    Bondil P; Dorémieux J; Nguyen Qui JL
    J Urol (Paris); 1987; 93(6):361-8. PubMed ID: 3323319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E1 in the therapy of erectile deficiency.
    Beretta G; Zanollo A; Ascani L; Re B
    Acta Eur Fertil; 1989; 20(5):305-8. PubMed ID: 2636808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Purulent cavernitis as a complication of self injection into the cavernous body].
    Schwarzer JU; Hofmann R; Leyh H
    Urologe A; 1991 Jan; 30(1):70-1. PubMed ID: 2014589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Are intracavernous injections of drugs for impotence harmless?].
    Bondil P
    Acta Urol Belg; 1988; 56(2):202-10. PubMed ID: 3400526
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
    Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
    Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intracavernous injection of prostaglandin E1 as a diagnostic test in erectile dysfunction].
    Marín Lafuente JC; Sańchez Moreno Horencia M; Puy Figuero Echeverría M; Llarena Ibarguren R; Pertusa Peña C
    Arch Esp Urol; 1990; 43(6):661-3. PubMed ID: 2092621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamics of erection: current pharmacological findings].
    Dorémieux J
    Ann Urol (Paris); 1985; 19(5):327-32. PubMed ID: 2867735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of prostaglandins for diagnosis and treatment of erectile impotence.
    Merckx L; Vanwaeyenbergh J; De Bruyne R; Braeckman J; Keuppens F
    Acta Urol Belg; 1991; 59(3):47-52. PubMed ID: 1759665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
    Chen RN; Lakin MM; Montague DK; Ausmundson S
    J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 36. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Teaching the patient about intra-cavernous injections to prevent erectile dysfunction].
    Héron M
    Soins; 2007 Mar; (713):50-1. PubMed ID: 17419575
    [No Abstract]   [Full Text] [Related]  

  • 38. Biweekly intracavernous administration of papaverine for erectile dysfunction.
    Mooradian AD; Morley JE; Kaiser FE; Davis SS; Viosca SP; Korenman SC
    West J Med; 1989 Nov; 151(5):515-7. PubMed ID: 2603417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood gas changes in the corpora cavernosa: metabolic and histomorphometric implications in the patient with erectile dysfunction.
    Sasso F; Falabella R; Gentile G; Servello C; Gulino G
    J Urol; 2003 Jun; 169(6):2270-4. PubMed ID: 12771768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role and practical application of a diagnostic test using papaverine in erection dysfunction].
    Henriet JP; Maiza D
    Phlebologie; 1990; 43(4):579-86. PubMed ID: 2093908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.